---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-001710"
form_type: "8-K"
ticker: "SRTS"
cik: "0001494891"
company_name: "Sensus Healthcare, Inc."
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-16T23:37:56.993836+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sensus Q3 2025: Revenue down 21.6% to $6.9M; net loss of $0.9M vs profit of $1.2M a year ago

## Summary
- Net loss of $0.9M ($0.06 per share) vs net income of $1.2M ($0.07 diluted) in Q3 2024.
- Revenue fell 21.6% to $6.9M; gross margin dropped to 39.1% from 59.1%.
- Shipped 16 SRT systems (vs 27 last year), including 3 to China; 21 FDA sites active.
- CMS published first-ever dedicated CPT® codes for SRT, improving reimbursement certainty.
- Exited quarter with $24.5M cash, no debt; nearly 100 systems in inventory.

## SEC filing metadata
- accession: 0001753926-25-001710
- form_type: 8-K
- ticker: SRTS
- cik: 0001494891
- company_name: Sensus Healthcare, Inc.
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1494891/000175392625001710/0001753926-25-001710-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1494891/000175392625001710/g084998_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-001710
- JSON: https://secwatch.observer/filing/0001753926-25-001710.json
- Plain text: https://secwatch.observer/filing/0001753926-25-001710.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.